| Marissa Janene Mannetta, LMHC | |
|
7635 Ashley Park Ct Ste 503h, Orlando, FL 32835-6197 | |
| (407) 963-4733 | |
| (407) 215-9436 |
| Full Name | Marissa Janene Mannetta |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 7635 Ashley Park Ct Ste 503h, Orlando, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003171547 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | MH17360 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Marissa Janene Mannetta, LMHC 7635 Ashley Park Ct Ste 503h, Orlando, FL 32835-6197 Ph: (407) 963-4733 | Marissa Janene Mannetta, LMHC 7635 Ashley Park Ct Ste 503h, Orlando, FL 32835-6197 Ph: (407) 963-4733 |
News Archive
The American College of Physicians (ACP) today urged the Department of Health and Human Services (HHS) to use the International Classification of Diseases (ICD-10) implementation delay to consider specifying the use of Systemized Nomenclature of Medicine - Clinical Term (SNOMED-CT), rather than ICD-10, for coding problems in all situations.
A multi-center clinical trial led by a Riley Hospital for Children endocrinologist has found that inhaled growth hormone (GH) is well tolerated by children with GH deficiency and that this easy-to-use method can, over a one-week period, safely deliver GH to the blood stream. In addition to having implications for those who need GH, this first pediatric study of administering it through the lungs may also help researchers interested in using this convenient method for effectively delivering other types of medications to children.
Health Secretary John Reid today published Choosing Health – the Government's White Paper on improving public health in England.
Investigators have found that young children with type 1 diabetes (T1D) have slower brain growth compared to children without diabetes. A new study, published in the December issue of Diabetes, now available ahead of print, suggests that continued exposure to hyperglycemia, or high blood sugars, may be detrimental to the developing brain.
Signum Biosciences, Inc. was recently awarded two Small Business Innovation Research (SBIR) Phase I grants by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a division of the NIH, totaling over $684,000 for development of novel G-protein coupled receptor (GPCR) modulating therapeutics designed to treat common skin disorders.
› Verified 8 days ago
Enrique Vela, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2540 Decker Ave, Orlando, FL 32833 Phone: 407-568-6978 | |
Sheena Allman, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1800 Mercy Dr., Suite 302, Orlando, FL 32808 Phone: 407-875-3700 Fax: 407-522-4671 | |
Jaskara L Castillo, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1800 Mercy Dr, Suite 302, Orlando, FL 32808 Phone: 407-875-3700 Fax: 407-522-4671 | |
Terrence D Woodard, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1800 Mercy Dr, Suite 302, Orlando, FL 32808 Phone: 407-875-3700 Fax: 407-522-4671 | |
Danielle Henry, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1800 Mercy Dr, Suite 302, Orlando, FL 32808 Phone: 407-875-3700 Fax: 407-522-4671 | |
Nelson Parra, Counselor Medicare: Not Enrolled in Medicare Practice Location: 4446 Andover Cay Blvd, Orlando, FL 32825 Phone: 407-405-8090 |